p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jun 1995

Hughes J H, Cohen M B, Robinson R A

Abstract excerpt

p53 is a tumor suppressor protein that is overexpressed in a variety of human neoplasms, including prostatic adenocarcinoma. Recent studies have demonstrated a significant positive correlation between extent of p53 overexpression and tumor grade in prostatic adenocarcinoma. Because it appears tha...

Topics

Adenocarcinoma
Antibodies, Monoclonal
Bone Neoplasms
Gene Expression Regulation, Neoplastic
Genes, p53
Humans
Immunohistochemistry
Lymphatic Metastasis
Male
Mutation
Prostatic Neoplasms
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 7675761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7675761-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics